Silvana Nair Leite (Silvana N Leite)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Venues

Ciencia & saude coletiva

Expert opinion on drug safety

PloS one

Pharmacy practice

Universidade Federal de Santa Catarina

Universidade de São Paulo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidade Federal de Santa Catarina Aug 19 2010

Brazil

Professor :: Ciencias Farmacêuticas

Education History

Universidade de São Paulo Aug 01 2000 - Aug 05 2005

Brazil

PHD :: Saude Publica

Publications

Samara Jamile Mendes, Myllena Farisco, Silvana Nair Leite, Sílvia Storpirtis
A broad view of pharmaceutical services in multidisciplinary teams of public Primary Healthcare Centers: a mixed methods study in a large city in Brazil. Primary health care research & development 23 (2022)
Mareni Rocha Farias, Silvana Nair Leite, Norberto Rech Bonetti, Jorge Antonio Zepeda Bermudez
Access to medicines: from intellectual property through to the incorporation into the health systems. Ciencia & saude coletiva 26 (11) (2022)
Andrigo Antonio Lorenzoni, Fabiola Bagatini Buendgens, Fernanda Manzini, Norberto Rech Bonetti, Silvana Nair Leite
A Comprehensive Understanding of the Use of e-Learning in Continuing Education: Experiences of Pharmacists in a Public Health System. Inquiry : a journal of medical care organization, provision and financing 58 (2022)
Silvana Nair Leite, Jorge Antonio Zepeda Bermudez, Débora Melecchi, Adelir Rodrigues da Veiga, Ana Liani Beisl Oliveira, Artur Custódio Moreira de Sousa, Célia Machado Gervásio Chaves, Fernanda Manzini, Lidiane Silva Dutra, Luisa Arueira Chaves, Marco Aurélio Pereira, Maria Eufrásia Oliveira Lima, Moysés Longinho Toniolo, Ronald Ferreira Dos Santos, Silvânia Dantas, Jorge Carlos Santos da Costa
Integra Project: strengthening social participation in the agenda of health policies, services, and technologies. Ciencia & saude coletiva 26 (11) (2021)
Geison Vicente, Cássia Cunico, Silvana Nair Leite
Transforming uncertainties into legitimate regulation? NICE and CONITEC agencies' decisions on rare diseases. Ciencia & saude coletiva 26 (11) (2021)
Karina de Oliveira Fatel, Marina Raijche Mattozo Rover, Samara Jamile Mendes, Silvana Nair Leite, Sílvia Storpirtis
Challenges in the management of high-priced drugs in the SUS: evaluation of Pharmaceutical Policy in São Paulo, Brazil. Ciencia & saude coletiva 26 (11) (2021)
Soraya Machado de Jesus, Rafael Santos Santana, Silvana Nair Leite
Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety? Expert opinion on drug safety (2021)
Silvana Nair Leite, Mirelle Finkler, Jussara Gue Martini, Ivonete Terezinha Schülter Buss Heidemann, Marta Inez Machado Verdi, Fernando Hellmann, Maria Fernanda Vásquez
Management of the health workforce in facing COVID-19: disinformation and absences in Brazil's Public Policies. Ciencia & saude coletiva 26 (5) (2021)
Marina Raijche Mattozo Rover, Emília Baierle Faraco, Claudia Marcela Vargas-Peláez, Claudia Flemming Colussi, Sílvia Storpirtis, Mareni Rocha Farias, Silvana Nair Leite
Access to high-priced medicines: inequalities in the organization and the results among Brazilian states. Ciencia & saude coletiva 26 (11) (2020)
Emília Baierle Faraco, Luciano Santos Pinto Guimarães, Claire Anderson, Silvana Nair Leite
The pharmacy workforce in public primary healthcare centers: promoting access and information on medicines. Pharmacy practice 18 (4) (2020)
Rafael Santos Santana, Evandro de Oliveira Lupatini, Fernando Zanghelini, Ricardo de March Ronsoni, Norberto Rech, Silvana Nair Leite
The different clinical guideline standards in Brazil: High cost treatment diseases versus poverty-related diseases. PloS one 13 (10) (2018)

Silvana Nair Leite.css-eqlu8i{font-size:small;padding-left:4px;} (Silvana N Leite)

Publication Activity (10 Years)

Top Topics

Top Venues

Silvana Nair Leite (Silvana N Leite)